SCHEMBL3958713

SCHEMBL3958713

NC(=O)C(=O)N1CC(CCN2CCN(c3ccc4[nH]ccc4c3)CC2)c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 3/20 0.47
DRD2 P14416 4/20 0.45
HTR1A P08908 2/20 0.45
HTR2A P28223 1/20 0.45
DRD4 P21917 3/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
DRD3 P35462 3/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
PRKACA P17612 1/20 0.38
PRKACG P22612 1/20 0.38
PRKACB P22694 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
FAAH O00519 1/20 0.37
MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3958707 1.00 HTR7 (0.47) HTR7DRD2HTR1AHTR2ADRD4
SCHEMBL3964423 0.94 HTR7 (0.47) HTR7DRD2HTR1AHTR2ADRD4
SCHEMBL3964417 0.94 HTR7 (0.47) HTR7DRD2HTR1AHTR2ADRD4
Hydrochloric Acid SCHEMBL3964753 0.94 HTR7 (0.46) HTR7DRD2HTR1AHTR2ADRD4
Hydrochloric Acid SCHEMBL3967087 0.94 HTR7 (0.46) HTR7DRD2HTR1AHTR2ADRD4
SCHEMBL7215989 0.91 DRD2 (0.55) HTR7DRD2HTR1AHTR2ADRD4
SCHEMBL3964456 0.88 HTR7 (0.45) HTR7DRD2HTR1AHTR2ADRD4
SCHEMBL3956623 0.88 HTR7 (0.45) HTR7DRD2HTR1AHTR2ADRD4
SCHEMBL3956617 0.88 HTR7 (0.45) HTR7DRD2HTR1AHTR2ADRD4
Hydrochloric Acid SCHEMBL3965460 0.87 HTR7 (0.45) HTR7DRD2HTR1AHTR2ADRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544685-B2 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2009-06-09 US claimed
CN-101243075-A Novel 2,3-dihydroindole compounds LUNDBECK & CO AS H (DK) 2008-08-13 CN claimed
US-20070043058-A1 Novel 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2007-02-22 US claimed
US-7544685-B2 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2009-06-09 US disclosed
CN-101243075-A Novel 2,3-dihydroindole compounds LUNDBECK & CO AS H (DK) 2008-08-13 CN disclosed
EP-1928860-A1 NOVEL 2,3-DIHYDROINDOLE COMPOUNDS H.Lundbeck A/S (DK) 2008-06-11 EP disclosed
WO-2007019867-A1 NOVEL 2,3-DIHYDROINDOLE COMPOUNDS H. LUNDBECK A/S (DK) 2007-02-22 WO disclosed
US-20070043058-A1 Novel 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043058-A1 Novel 2,3-dihydroindole compounds HTR2C, HTR2A, HTR5A HTR7 20/4885DRD2 24/4885HTR1A 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.